SPP1 and chronic obstructive pulmonary disease: Thus, these findings suggest macrophages (particularly Macro_SPP1 cells) as key regulators of T cell dysfunction and identify SPP1 and GALECTIN signaling pathways as potential therapeutic targets for restoring immune homeostasis in COPD airways.